For European medical/trade media only: Clinical practice data demonstrates clinical effectiveness and tolerability of Zebinix® (eslicarbazepine acetate) as adjunctive therapy in epilepsy patients with psychiatric comorbidities
For UK medical/trade & consumer health media only: Eisai and MSD announce Scottish Medicines Consortium recommendation of new first-line treatment Lenvima® ▼ (lenvatinib) for adults with advanced, unresectable hepatocellular carcinoma
For European medical media only: New pan-European report highlights feeling of isolation among people with metastatic breast cancer and need for healthcare professionals to care for emotional demands of disease
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.
Click 'cancel' to return to Eisai's site or 'continue' to proceed.